CAMBRIDGE, Mass.--(BUSINESS WIRE)--Hydra Biosciences, a leader in the field of Transient Receptor Potential (TRP) ion channel modulation in the areas of pain, inflammation, renal disease, anxiety and pulmonary disease, today announced that Russell Herndon, President and CEO, will provide a company update at the 8th Annual Biotech Showcase conference in San Francisco. The presentation is at the Parc 55 Hilton Hotel on Jan. 11, 2016, at 3:15 p.m. PST in the Davidson room.
